Energy Medicine. Personal Experience. Impact. Growth in Asia. Ideas
This is an invest-able idea at the private level  with long term benefits. Both for the body, and for other ideas as well.Ever since I turned over...
4k Views
MS-China Index Earning Revision (Mar): PDD, UNITED NOVA TECHNOLOGY, MEITUAN, TENCENT, ALIBABA
We analyzed MS-China's consensus for Mar 2026 and highlighted changes of EPS in PDD, UNITED NOVA TECHNOLOGY, MEITUAN, TENCENT, ALIBABA, TCL...
446 Views
Can Innovation labs be assessed to pick stocks for your portfolio?
Companies across different industries are building Innovation centers in Singapore, Hong Kong and other cities across Asia and the rest of the...
936 Views
Hutchison Whampoa Restructuring: Next Move for Watson's?
The announced restructuring of Cheung Kong Limited and Hutchison Whampoa Limited has been well received on the HKEx. Hutchison shares have rallied...
654 Views
Ascentage Pharma (6855.HK) Placement - Thoughts on The Placing Price and the Outlook
The Placing price of HK$68.6 has priced in successful licensing deal of APG-2575. US$1.5-2.375bn is a more reasonable valuation. Biotech sector...
894 Views